| 1 |
33637776 | BKM120 sensitizes BRCA-proficient triple negative breast cancer cells to olaparib through regulating FOXM1 and Exo1 expression. | 2021 Feb 26 |
2 |
| 2 |
34039959 | BKM120 sensitizes glioblastoma to the PARP inhibitor rucaparib by suppressing homologous recombination repair. | 2021 May 26 |
1 |
| 3 |
28945226 | PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy. | 2018 Jan 18 |
1 |
| 4 |
27426307 | Combined inhibition of PI3K and PARP is effective in the treatment of ovarian cancer cells with wild-type PIK3CA genes. | 2016 Sep |
1 |
| 5 |
22915752 | PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition. | 2012 Nov |
1 |